Patients with TBI undergoing experimental regenerative cell treatment in Japan.

Patients with TBI undergoing experimental regenerative cell treatment in Japan.
April 21, 2016, Kitchener, Ontario Posted by: Robert Deutschmann, Personal Injury Lawyer There is some interesting new hope for sufferers of chronic TBI. SanBIO has announced that they are staring the world’s first phase 2 trials of treatment for TBI will stem cells. The trials, in Japan, will be on 52 patients. The drug SB623 is a regenerative cell medicine. It has been shown to improve outcomes in patients with ischemic stroke who have persistent motor deficits. These new trials will be on patients with TNI. The stem cells are derived from bone marrow harvested from healthy adults and it works in neural tissue by promoting triggering the brain’s natural regenerative ability. Hopes are high for the new drug. You can read about the company and the cell therapy on their website.
Posted under Brain Injury, Personal Injury, Spinal Cord Injury, Treatment View All Posts
About Deutschmann Law Deutschmann Law serves South-Western Ontario with offices in Kitchener-Waterloo, Cambridge, Woodstock, Brantford, Stratford and Ayr. The law practice of Robert Deutschmann focuses almost exclusively in personal injury and disability insurance matters. For more information, please visit www.deutschmannlaw.com or call us at 1-519-742-7774. The opinions expressed here, while intended to provide useful information, should not be interpreted as legal recommendations or advice.